The Choledochoscope segmentation by application distinguishes three primary use‑cases that collectively drive market revenue. Diagnostic applications encompass cholangiography, stone detection, and anatomical mapping, accounting for roughly 40 % of total sales as hospitals invest in high‑resolution imaging to reduce invasive procedures. Therapeutic usage, representing the largest share at about 45 %, includes stone extraction, stricture dilation, and tumor biopsy, where the instrument’s maneuverability directly influences procedural success rates and thus procurement volumes. The remaining research segment, estimated at 15 %, covers clinical trials, device validation, and academic studies that, while smaller in spend, stimulate innovation and early‑adoption cycles. Each application contributes proportionally to the overall Choledochoscope market size by aligning purchase decisions with clinical demand, reimbursement structures, and technological advancement, creating a balanced portfolio that sustains growth across diverse healthcare settings.